Influenza vaccine codes for exposure identification
retiredURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.49Copied!
Version20211123Copied!
PublisherBEST System StewardDate2021-11-23T01:02:05-05:00Purpose(Clinical Focus: Influenza vaccine codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine codes, including CPT/HCPCS, RxNorm, and CVX.),(Exclusion Criteria: None)
Expansion
Expansion error
Can't resolve code system: http://www.nlm.nih.gov/research/umls/hcpcs
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.47
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.48
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.46
valueSethttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.45
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.47" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.48" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.46" ]
}, {
"valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.45" ]
} ]
},
"date" : "2021-11-23T01:02:05-05:00",
"meta" : {
"versionId" : "8",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "BEST System Steward",
"jurisdiction" : [ {
"coding" : [ {
"system" : "urn:iso:std:iso:3166",
"code" : "US"
} ]
} ],
"purpose" : "(Clinical Focus: Influenza vaccine codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: Influenza vaccine codes, including CPT/HCPCS, RxNorm, and CVX.),(Exclusion Criteria: None)",
"name" : "InfluenzaVaccineCodesForExposureIdentification",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "111",
"display" : "influenza virus vaccine, live, attenuated, for intranasal use",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "123",
"display" : "influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "125",
"display" : "Novel Influenza-H1N1-09, live virus for nasal administration",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "126",
"display" : "Novel influenza-H1N1-09, preservative-free, injectable",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "127",
"display" : "Novel influenza-H1N1-09, injectable",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "128",
"display" : "Novel influenza-H1N1-09, all formulations",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "135",
"display" : "influenza, high dose seasonal, preservative-free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "140",
"display" : "Influenza, seasonal, injectable, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "141",
"display" : "Influenza, seasonal, injectable",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "144",
"display" : "seasonal influenza, intradermal, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "149",
"display" : "influenza, live, intranasal, quadrivalent",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "15",
"display" : "influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "150",
"display" : "Influenza, injectable, quadrivalent, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "151",
"display" : "influenza nasal, unspecified formulation",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "153",
"display" : "Influenza, injectable, Madin Darby Canine Kidney, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "155",
"display" : "Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "158",
"display" : "influenza, injectable, quadrivalent, contains preservative",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "16",
"display" : "influenza virus vaccine, whole virus",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "160",
"display" : "Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "161",
"display" : "Influenza, injectable,quadrivalent, preservative free, pediatric",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "166",
"display" : "influenza, intradermal, quadrivalent, preservative free, injectable",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "168",
"display" : "Seasonal trivalent influenza vaccine, adjuvanted, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "171",
"display" : "Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent",
"version" : "20240315"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "1804259",
"display" : "influenza A virus A/Vietnam/1203/2004 (H5N1) antigen",
"version" : "05062024"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "185",
"display" : "Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "186",
"display" : "Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "194",
"display" : "influenza, Southern Hemisphere, unspecified formulation",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "197",
"display" : "influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "200",
"display" : "influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "201",
"display" : "influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "202",
"display" : "influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "205",
"display" : "influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free",
"version" : "20240315"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2050418",
"display" : "0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2050422",
"display" : "Fluzone 2018-2019 Injectable Product",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2050423",
"display" : "0.5 ML influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2018-2019]",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2050776",
"display" : "Fluzone Quadrivalent 2018-2019 Injectable Product",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2050787",
"display" : "influenza A virus A/Michigan/45/2015 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Singapore/INFIMH-16-0019/2016 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2018-2019]",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177494",
"display" : "Fluzone Quadrivalent 2019-2020 Injectable Product",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177503",
"display" : "0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177504",
"display" : "0.25 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2019-2020]",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177590",
"display" : "influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177592",
"display" : "influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2019-2020]",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177692",
"display" : "0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177696",
"display" : "Fluzone 2019-2020 Injectable Product",
"version" : "05062024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2177697",
"display" : "0.5 ML influenza A virus A/Brisbane/02/2018 (H1N1) antigen 0.12 MG/ML / influenza A virus A/Kansas/14/2017 (H3N2) antigen 0.12 MG/ML / influenza B virus B/Maryland/15/2016 antigen 0.12 MG/ML Prefilled Syringe [Fluzone 2019-2020]",
"version" : "05062024"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "69",
"display" : "parainfluenza-3 virus vaccine",
"version" : "20240315"
}, {
"system" : "http://hl7.org/fhir/sid/cvx",
"code" : "88",
"display" : "influenza virus vaccine, unspecified formulation",
"version" : "20240315"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90630",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90653",
"display" : "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90654",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90655",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90656",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90657",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90658",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90660",
"display" : "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90661",
"display" : "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90662",
"display" : "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90664",
"display" : "Influenza virus vaccine, live (LAIV), pandemic formulation, for intranasal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90666",
"display" : "Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90667",
"display" : "Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90668",
"display" : "Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90672",
"display" : "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90673",
"display" : "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90674",
"display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90682",
"display" : "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90685",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90686",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90687",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90688",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90694",
"display" : "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.ama-assn.org/go/cpt",
"code" : "90756",
"display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "G0008",
"display" : "Administration of influenza virus vaccine",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "Q2034",
"display" : "Influenza virus vaccine, split virus, for intramuscular use (agriflu)",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "Q2035",
"display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "Q2036",
"display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "Q2037",
"display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "Q2038",
"display" : "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)",
"version" : "2024"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "Q2039",
"display" : "Influenza virus vaccine, not otherwise specified",
"version" : "2024"
} ],
"total" : 78,
"identifier" : "urn:uuid:e5d6cdc3-03d4-40eb-bbcf-38281fc275d8",
"timestamp" : "2024-06-14T14:38:38-04:00"
},
"title" : "Influenza vaccine codes for exposure identification",
"extension" : [ {
"valueString" : "BEST System Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2024-06-03",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2021-11-23",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "retired",
"id" : "2.16.840.1.113762.1.4.1234.49",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.49",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1234.49"
} ],
"version" : "20211123"
}